Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice
Authors:
- 1 March 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (6) , 782-785
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practiceAmerican Heart Journal, 1998
- Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With ThrombolysisCirculation, 1998
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- Individual risk assessment for intracranial haemorrhage during thrombolytic therapyThe Lancet, 1993
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic TreatmentNew England Journal of Medicine, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionThe Lancet, 1992
- Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).BMJ, 1991
- Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.Circulation, 1991
- Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarctionThe American Journal of Medicine, 1988